TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma

Tumors that lack pre-existing immune infiltration respond poorly to T cell checkpoint blockade immunotherapy. These cancers often surround themselves with high densities of suppressive myeloid stroma while excluding immunostimulatory dendritic cells. Tumor-resident myeloid cells and selected lymphoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Reilley, Matthew J., Morrow, Brittany, Ager, Casey R., Liu, Arthur, Hong, David S., Curran, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880482/
https://www.ncbi.nlm.nih.gov/pubmed/31771649
http://dx.doi.org/10.1186/s40425-019-0811-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880482/
https://www.ncbi.nlm.nih.gov/pubmed/31771649
http://dx.doi.org/10.1186/s40425-019-0811-x

Ejemplares similares